UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 264

Sortiert nach

Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2

Journal of medicinal chemistry, 2021-03, Vol.64 (5), p.2829-2848

2021

Link zum Volltext

Verfügbarkeit prüfen

Covalent Construction of Sustainable Hybrid UiO-66-NH2@Tb-CP Material for Selective Removal of Dyes and Detection of Metal Ions

ACS sustainable chemistry & engineering, 2019-02, Vol.7 (3), p.3203-3212

2019

Link zum Volltext

Verfügbarkeit prüfen

Covalent inhibitors of EZH2: Design, synthesis and evaluation

Biomedicine & pharmacotherapy, 2022-03, Vol.147, p.112617-112617, Article 112617

2022

Link zum Volltext

Verfügbarkeit prüfen

Multifunctional Ln–MOF Luminescent Probe for Efficient Sensing of Fe3+, Ce3+, and Acetone

ACS applied materials & interfaces, 2018-07, Vol.10 (28), p.23976-23986

2018

Link zum Volltext

Verfügbarkeit prüfen

Transformational Modulation of Fluorescence to Room Temperature Phosphorescence in Metal–Organic Frameworks with Flexible C–S–C Bonds

ACS applied materials & interfaces, 2024-03, Vol.16 (9), p.11730-11739

2024

Link zum Volltext

Verfügbarkeit prüfen

Discovery of novel G9a/GLP covalent inhibitors for the treatment of triple-negative breast cancer

European journal of medicinal chemistry, 2023-12, Vol.261, p.115841-115841, Article 115841

2023

Link zum Volltext

Verfügbarkeit prüfen

The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis

Journal of molecular cell biology, 2021-04, Vol.13 (1), p.3

2021

Link zum Volltext

Verfügbarkeit prüfen

NQO1 and viscosity tandemly responsive NIR fluorescent probe for tumor imaging and monitoring tumor apoptosis

Sensors and actuators. B, Chemical, 2024-11, Vol.418, p.136247, Article 136247

2024

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis and evaluation of antitumor activity of selective PRMT6 inhibitors

European journal of medicinal chemistry, 2023-02, Vol.247, p.115032, Article 115032

2023

Link zum Volltext

Verfügbarkeit prüfen

Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH

Life sciences (1973), 2024-04, Vol.342, p.122538-122538, Article 122538

2024

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo

Biochemical pharmacology, 2023-04, Vol.210, p.115493-115493, Article 115493

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological inhibition of EZH2 using a covalent inhibitor suppresses human ovarian cancer cell migration and invasion

Molecular and cellular biochemistry, 2024-04, Vol.479 (4), p.831-841

2024

Link zum Volltext

Verfügbarkeit prüfen

Focus on the classical and non-classical functions of EZH2: Guide the development of inhibitors and degraders

Pharmacological research, 2022-04, Vol.178, p.106159-106159, Article 106159

2022

Link zum Volltext

Verfügbarkeit prüfen

A TICT-AIE activated dual-channel fluorescence-on probe to reveal the dynamics mechanosensing of lipid droplets during ferroptosis

Talanta (Oxford), 2024-07, Vol.274, p.126028-126028, Article 126028

2024

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer

Journal of medicinal chemistry, 2023-02, Vol.66 (3), p.1725-1741

2023

Link zum Volltext

Verfügbarkeit prüfen

Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Cancer

Journal of medicinal chemistry, 2022-12, Vol.65 (24), p.16541-16569

2022

Link zum Volltext

Verfügbarkeit prüfen

Anti-tumor activity of SKLB-0322, a novel EZH2 covalent inhibitor, in ovarian cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15052-e15052

2021

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor

European journal of medicinal chemistry, 2024-09, Vol.275, p.116612, Article 116612

2024

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a first-in-class degrader for the protein arginine methyltransferase 6 (PRMT6)

Bioorganic chemistry, 2024-07, Vol.148, p.107439-107439, Article 107439

2024

Link zum Volltext

Verfügbarkeit prüfen

A patent review of EZH2 inhibitors from 2017 and beyond

Expert opinion on therapeutic patents, 2023-04, Vol.33 (4), p.293-308

2023

Link zum Volltext

Verfügbarkeit prüfen

Design and synthesis of (E)-1,2-diphenylethene-based EZH2 inhibitors

Bioorganic & medicinal chemistry letters, 2020-03, Vol.30 (5), p.126957, Article 126957

2020

Link zum Volltext

Verfügbarkeit prüfen

Discovery of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives as novel tubulin polymerization inhibitors for treatment of cancer

European journal of medicinal chemistry, 2019-12, Vol.184, p.111728-111728, Article 111728

2019

Link zum Volltext

Verfügbarkeit prüfen

The discovery of SKLB-0335 as a paralog-selective EZH2 covalent inhibitor

Chemical communications (Cambridge, England), 2021-03, Vol.57 (24), p.36-39

2021

Link zum Volltext

Verfügbarkeit prüfen

Multifunctional fluorescent probe for simultaneous revealing Cys and ONOO– dynamic correlation in the ferroptosis

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2024-07, Vol.315, p.124248, Article 124248

2024

Link zum Volltext

Verfügbarkeit prüfen

Thermal control over phosphorescence or thermally activated delayed fluorescence in a metal-organic framework

Chemical science (Cambridge), 2024-06, Vol.15 (23), p.895-8912

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 264

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(248)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(194)
Life Sciences & Biomedicine
(104)
Technology
(70)
Humans
(54)
Physical Sciences
(49)
Materials Science
(44)
Engineering
(31)
Chemistry
(29)
Materials Science, Multidisciplinary
(29)
Oncology
(27)
Pancreatic Cancer
(22)
Animals
(21)
Cell Line, Tumor
(21)
Female
(21)
Pharmacology & Pharmacy
(21)
Physics
(21)
Physics, Applied
(18)
Proteins
(18)
Cancer
(17)
Cell Proliferation
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2

Covalent Construction of Sustainable Hybrid UiO-66-NH2@Tb-CP Material for Selective Removal of Dyes and Detection of Metal Ions

Covalent inhibitors of EZH2: Design, synthesis and evaluation

Multifunctional Ln–MOF Luminescent Probe for Efficient Sensing of Fe3+, Ce3+, and Acetone

Transformational Modulation of Fluorescence to Room Temperature Phosphorescence in Metal–Organic Frameworks with Flexible C–S–C Bonds

Discovery of novel G9a/GLP covalent inhibitors for the treatment of triple-negative breast cancer

The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis

NQO1 and viscosity tandemly responsive NIR fluorescent probe for tumor imaging and monitoring tumor apoptosis

Design, synthesis and evaluation of antitumor activity of selective PRMT6 inhibitors

Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH

Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo

Pharmacological inhibition of EZH2 using a covalent inhibitor suppresses human ovarian cancer cell migration and invasion

Focus on the classical and non-classical functions of EZH2: Guide the development of inhibitors and degraders

A TICT-AIE activated dual-channel fluorescence-on probe to reveal the dynamics mechanosensing of lipid droplets during ferroptosis

Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer

Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Cancer

Anti-tumor activity of SKLB-0322, a novel EZH2 covalent inhibitor, in ovarian cancer

Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor

Discovery of a first-in-class degrader for the protein arginine methyltransferase 6 (PRMT6)

A patent review of EZH2 inhibitors from 2017 and beyond

Design and synthesis of (E)-1,2-diphenylethene-based EZH2 inhibitors

Discovery of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives as novel tubulin polymerization inhibitors for treatment of cancer

The discovery of SKLB-0335 as a paralog-selective EZH2 covalent inhibitor

Multifunctional fluorescent probe for simultaneous revealing Cys and ONOO– dynamic correlation in the ferroptosis

Thermal control over phosphorescence or thermally activated delayed fluorescence in a metal-organic framework

Suchergebnisse filtern